๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for NSCLC Stage II

Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC NCT06929936Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: Trilaciclib combined with Docetaxel An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Zhengzhou๐Ÿ“ Hangzhou Beijing Tide Pharmaceutical Co., Ltd ยท Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC NCT06844474Phase 21 site๐Ÿ“ Beijing Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-1826๏ผ›Adebrelimab๏ผ›SHR-8068๏ผ›Bevacizumab A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC NCT06467617Phase 21 site๐Ÿ“ Beijing Beijing Chest Hospital, Capital Medical University ยท Tests: Adebrelimab plus albumin-bound paclitaxel, carboplatin and recaticimab Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer NCT05751018Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Pyrotinib Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer NCT04992780Phase 26 sites๐Ÿ“ Kansas City๐Ÿ“ Overland Park๐Ÿ“ Topeka University of Kansas Medical Center ยท Tests: Hypo-Fractionation, Standard-Fractionation Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy NCT05398094Phase 220 sites๐Ÿ“ Alicante๐Ÿ“ Badalona๐Ÿ“ Barcelona Fundaciรณn GECP ยท Tests: Sotorasib A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) NCT05657873Phase 29 sites๐Ÿ“ Miami๐Ÿ“ Basking Ridge๐Ÿ“ Middletown Memorial Sloan Kettering Cancer Center ยท Tests: L-SABR, Anti-PD-(L)1 based immunotherapy, Platinum based chemotherapy T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer NCT02133196Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Aldesleukin, Fludarabine, Cyclophosphamide, Young TIL A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer NCT07082179Phase 21 site๐Ÿ“ Nanjing Jiangsu Cancer Institute & Hospital ยท Tests: Iparomlimab and Tuvonralimab combined with paclitaxel polymer micelles and Platinum (cisplatin/carboplatin) Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer NCT07323641Phase 21 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Osimertinib Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC NCT07492342Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Zhejiang Jianxing He ยท Tests: fulzerasib A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC) NCT07622186Phase 227 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Fuzhou Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ยท Tests: SKB571 for injection, Osimertinib, Furmonertinib, carboplatin, Cisplatin Osimertinib for Advanced EGFR-positive NSCLC Patients NCT05037331n/a1 site๐Ÿ“ Singapore National University Hospital, Singapore Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) NCT07154706Phase 333 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ Washington D.C. Nuvation Bio Inc. ยท Tests: Taletrectinib, Placebo RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC NCT07541521n/a10 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Shanghai Chest Hospital ยท Tests: Robot-assisted thoracoscopic surgery (RATS) sleeve lobectomy TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases NCT05948813Phase 21 site๐Ÿ“ Beijing TYK Medicines, Inc ยท Tests: TY-9591, Osimertinib Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site๐Ÿ“ Beijing Guangzhou JOYO Pharma Co., Ltd ยท Tests: JYP0015 Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC NCT03694236Phase 1, Phase 21 site๐Ÿ“ Seoul Yonsei University ยท Tests: durvalumab Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC NCT03872661Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: IBI308, Bevacizumab, Pemetrexed, Carboplatin, Thoracic surgery Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer NCT05292521NA1 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Best Practice, Informational Intervention, Questionnaire Administration Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients NCT06311981Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: carbon ion radiotherapy, targeted therapy, single regimen chemotherapy in sequence with radiotherapy A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC NCT06769295Phase 21 site๐Ÿ“ Chengdu Sichuan University ยท Tests: AK112 A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC NCT06754930Phase 1, Phase 21 site๐Ÿ“ Shanghai Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-1826, SHR-1316, SHR-9839, SHR-8068, Ametinib mesylate IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC NCT05994131Phase 1, Phase 21 site๐Ÿ“ Shanghai InxMed (Shanghai) Co., Ltd. ยท Tests: IN10018, Furmonertinib Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation NCT07012031Phase 1, Phase 29 sites๐Ÿ“ Sacramento๐Ÿ“ Tampa๐Ÿ“ Tampa National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients NCT05933239Phase 21 site๐Ÿ“ Jette Universitair Ziekenhuis Brussel ยท Tests: 68GaNOTA-Anti-MMR-VHH2 Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC NCT05669846Phase 21 site๐Ÿ“ Pittsburgh Diwakar Davar ยท Tests: Healthy Donor Fecal Microbiota Transplant (hdFMT), Pembrolizumab A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC NCT07193641Phase 21 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Spatially Fractionated Radiotherapy (SFRT)+Stereotactic Body Radiation Therapy (SBRT), The systemic therapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy